Smith & Nephew Regulatory News (SN.)

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc ordinary shares of USD 0.20 each

Identification code

ISIN: GB0009223206

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2025 final dividend payment on 27 May 2026.

Date of Transaction

2026 - 05 - 27

Place of Transaction

London Stock Exchange (XLON)

Name

(Position)

Director / PDMR

Price

Volume

Aggregated information

Deepak Nath

(Chief Executive Officer)

Director

11.38002

6,259.14583

N/A Single Transaction

John Rogers

(Chief Financial Officer)

Director

11.38002

61.89914

N/A Single Transaction

Paul Connolly

(President, Global Operations)

PDMR

11.38002

1190.0452

N/A Single Transaction

Alison Parkes

(Chief Compliance Officer)

PDMR

11.38002

153.58792

N/A Single Transaction

Scott Schaffner

(President, Sports Medicine)

PDMR

11.38002

2148.33828

N/A Single Transaction